Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

296.74
Data as of Apr 17
 -3.40 / -1.13%
Today’s Change
203.70
Today|||52-Week Range
352.49
+7.81%
Year-to-Date
Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Ec...
Apr 16 / Benzinga
Health Care Stocks: Check Out This Low-Cost Market Beater
Apr 15 / MotleyFool.com
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner
Apr 16 / TheStreet.com
Another Earnings Beat from J&J, View Up - Analyst Blog
Apr 15 / Zacks.com
3 Stocks Reiterated As A Hold: TSLA, PM, REGN
Apr 16 / TheStreet.com
Gold miners suffer as bullion price dips
Apr 15 / FT.com
Will This Coverage Initiation Help Regeneron (REGN) Stock Today?
Apr 16 / TheStreet.com
Ambit Biosciences Slumps: AMBI Falls 13.0% in Session - Tale of the Tape
Apr 15 / Zacks.com
Anacor Pharma Remains Over-Valued on Development of Inferior Drugs
Apr 16 / TheStreet.com
Why Is Regeneron Pharmaceuticals, Inc. Bucking the Downtrend?
Apr 14 / MotleyFool.com
Good News for BioMarin - Analyst Blog
Apr 15 / Zacks.com
Orbimed Advisors Cuts Stake In Intercept Pharmaceuticals Inc (ICPT)
Apr 14 / Investing Channel
Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog
Apr 15 / Zacks.com
Top 40 Upcoming Earnings Releases
Apr 11 / Benzinga
Repros Completes Enrollment for Androxal Study - Analyst Blog
Apr 15 / Zacks.com
Tweet of the Week: Big Biotech Dominates Industry Gains
Apr 07 / MotleyFool.com
Encouraging Results from Lexicon Candidate - Analyst Blog
Apr 15 / Zacks.com
Stocks: brutal finale to week
Apr 04 / CNNMoney.com
FDA Nod for Merck's Grastek - Analyst Blog
Apr 15 / Zacks.com
Biotech Beatdown
Mar 21 / StockTwits
Portola's Betrixaban Study Design Published - Analyst Blog
Apr 15 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.